This list is based on the watchlists of people on Stock Events who follow 8LY.F. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
OncoZenge AB (publ), a pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden. It offers BupiZenge, which is in Phase 3 clinical trials for the treatment of pain in the oral cavity. The company was incorporated in 2020 and is headquartered in Bromma, Sweden.
Show more...
FAQ
What is OncoZenge AB stock price today?▼
The current price of 8LY.F is €0.55 EUR — it has increased by +3.56% in the past 24 hours. Watch OncoZenge AB stock price performance more closely on the chart.
What is OncoZenge AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange OncoZenge AB stocks are traded under the ticker 8LY.F.
Is OncoZenge AB stock price growing?▼
8LY.F stock has risen by +2.03% compared to the previous week, the month change is a +4.93% rise, over the last year OncoZenge AB has showed a +43.26% increase.
What is OncoZenge AB market cap?▼
Today OncoZenge AB has the market capitalization of 6.99M
What is OncoZenge AB revenue for the last year?▼
OncoZenge AB revenue for the last year amounts to 0 EUR.
What is OncoZenge AB net income for the last year?▼
8LY.F net income for the last year is -1.52M EUR.
How many employees does OncoZenge AB have?▼
As of April 29, 2026, the company has 1 employees.
In which sector is OncoZenge AB located?▼
OncoZenge AB operates in the Health & Wellness sector.
When did OncoZenge AB complete a stock split?▼
OncoZenge AB has not had any recent stock splits.
Where is OncoZenge AB headquartered?▼
OncoZenge AB is headquartered in Bromma, Sweden.